Supervisory Board

Compensation of the Members of the Supervisory Board

Compensation of the Members of the Supervisory Board of Bayer AG in 2014
  Fixed Compensation Attendance Fee Total
  2013 2014 2013 2014 2013 2014
  € thousand € thousand € thousand € thousand € thousand € thousand
Members of the Supervisory
Board as of December 31, 2014
Dr. Paul Achleitner 180 180 4 5 184 185
Dr. Simone Bagel-Trah 81 3 84
Dr. Clemens Börsig 120 120 4 4 124 124
André van Broich 120 120 4 5 124 125
Thomas Ebeling 120 120 4 4 124 124
Dr. Thomas Fischer 180 180 8 9 188 189
Peter Hausmann 150 150 4 4 154 154
Reiner Hoffmann 180 180 8 8 188 188
Yüksel Karaaslan 120 120 4 5 124 125
Petra Kronen 150 150 3 5 153 155
Dr. Helmut Panke 120 155 3 5 123 160
Sue H. Rataj 120 120 3 4 123 124
Petra Reinbold-Knape 120 120 3 4 123 124
Michael Schmidt-Kiessling 120 120 4 5 124 125
Dr. Klaus Sturany 240 240 8 8 248 248
Werner Wenning (Chairman) 360 360 8 10 368 370
Prof. Dr. Otmar D. Wiestler1 0 0 0
Thomas de Win (Vice Chairman) 240 240 7 7 247 247
Prof. Dr. Dr. Ernst-Ludwig Winnacker 120 120 4 5 124 125
Oliver Zühlke 150 150 4 5 154 155
             
Members who left the Supervisory
Board during 2014
Prof. Dr. Ekkehard D. Schulz 180 59 8 3 188 62
Dr. Klaus Kleinfeld 120 90 4 3 124 93
Total 3,210 3,175 99 111 3,309 3,286
1 Prof. Wiestler's office as Chairman of the Management Board of the German Cancer Research Center precludes his acceptance of compensation for membership of the Supervisory Board.

 

Details regarding the remuneration of the Board of Management can be found in our compensation report of the annual report 2014.

Last updated: April 20, 2015 Copyright © Bayer AG
http://www.bayer.com